UBS O'Connor’s Celularity Inc CELUW Stock Holding History

UBS O'Connor’s Portfolio CELUW Stock Details CELUW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-120,753	Closed	-$132K	–	886
2021 Q1	$132K	Buy	+120,753	New	+$188K	﹤0.01%	723

Other funds holding CELUW

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

EJF Capital Arlington, Virginia $142M AUM 23.3% 1-Year Est. Return

Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return

PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return

Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return

UBS O'Connor's CELUW Position: Q2 2021 in Review

UBS O'Connor sold out of Celularity Inc (CELUW) in Q2 2021, closing a stake of 120,753 shares — an estimated $132K sold.

UBS O'Connor first reported a position in CELUW in Q1 2021 and held it in 1 quarter. The position peaked at $132K in Q1 2021. 26 funds tracked by Wall St. Rank hold CELUW as of Q2 2021.

UBS O'Connor reported no remaining Celularity Inc position as of Q2 2021 after selling out during the quarter.
UBS O'Connor sold 120,753 Celularity Inc shares in Q2 2021, an estimated $132K.
UBS O'Connor first reported a position in Celularity Inc in Q1 2021 and held it in 1 quarter.
UBS O'Connor's Celularity Inc position peaked at $132K in Q1 2021.
26 funds tracked by Wall St. Rank held Celularity Inc as of Q2 2021.

Based on UBS O'Connor's 13F filing for Q2 2021, filed 13 Aug 2021.